Lena Hoffmann

Lena Hoffmann studied biochemistry at Ludwig Maximilian University of Munich and worked briefly in pharmaceutical research before discovering that she was better suited to explaining science than producing it. She has covered the biotech industry across Europe for twelve years, with deep expertise in gene therapy, CRISPR applications, and the growing field of personalised medicine. Lena is sceptical by nature — she has seen enough overhyped announcements to know the difference between a press release and a genuine leap forward — and her readers trust her for exactly that reason. Her writing is precise, clear, and honest about what the science does and doesn't yet prove. She is based in Munich.